The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia

Publisher: Bentham Science Publishers

E-ISSN: 1875-5739|12|4|398-403

ISSN: 1567-2026

Source: Current Neurovascular Research, Vol.12, Iss.4, 2015-09, pp. : 398-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content